Skip to content

Medication adherence and continuity of care (Observational study of impact of medication adherence on renal function in comorbid patients with type 2 diabetes and depression)

Medication adherence and continuity of care (Observational study of impact of medication adherence on renal function in comorbid patients with type 2 diabetes and depression) - Observational study on diabetes and depression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000017513
Enrollment
550
Registered
2015-05-22
Start date
2015-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes and depression

Interventions

None listed

Sponsors

National Center of Neurology and Psychiatry
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Outpatients with type 2 diabetes receiving hypoglycemic medications who can complete a questionnaire in Japanese.

Exclusion criteria

Exclusion criteria: Patients pregnant, with cognitive impairment, severe disease of the adrenal glands, liver dysfunction, or severe renal impairment (serum creatinine > 2.0 mg/dL)

Design outcomes

Primary

MeasureTime frame
Decline of renal function in subtypes categorized according to depression and adherence

Secondary

MeasureTime frame
Clinical variables, quality of life, and attitude of physicians toward depression

Countries

Japan

Contacts

Public ContactMegumi Hazumi

National Center of Neurology and Psychiatry Department of Mental Health Policy and Evaluation, National Institute of Mental Health

mhazumi@ncnp.go.jp042-341-2711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026